These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22629)

  • 21. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioral interactions of opioid agonists and antagonists with serotonergic systems.
    Rech RH; Mokler DJ; Commissaris RL; Henck JW
    NIDA Res Monogr; 1984 Mar; 49():179-84. PubMed ID: 6434957
    [No Abstract]   [Full Text] [Related]  

  • 25. Quipazine-metoclopramide inhibition of CB-154-induced prolactin suppression in rats: neurotransmitter-metabolite correlations.
    Lipham LB; Porter JK; Norred WP; Booth NH; Robbins JD
    Proc Soc Exp Biol Med; 1987 Mar; 184(3):250-5. PubMed ID: 2881309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of an autoreceptor modulating the release of [3H]5-hydroxytryptamine from a synaptosomal-rich spinal cord tissue preparation.
    Monroe PJ; Smith DJ
    J Neurochem; 1985 Dec; 45(6):1886-94. PubMed ID: 3877146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
    Pieri L; Keller HH; Burkard W; Da Prada M
    Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 30. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological evidence for the existence of multiple functional pools of brain serotonin: analysis of brain perfusate from conscious rats.
    Kleven MS; Dwoskin LP; Sparber SB
    J Neurochem; 1983 Oct; 41(4):1143-9. PubMed ID: 6194257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent effects of repeated injections of D-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels.
    Peters DA; Tang S
    Biochem Pharmacol; 1977 Jun; 26(11):1085-6. PubMed ID: 880261
    [No Abstract]   [Full Text] [Related]  

  • 33. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms].
    Hong E
    Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731
    [No Abstract]   [Full Text] [Related]  

  • 35. Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Eur J Pharmacol; 1977 Oct; 45(4):341-8. PubMed ID: 923645
    [No Abstract]   [Full Text] [Related]  

  • 36. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
    Lansdown MR; Nash HL; Preston PR; Wallis DI
    Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
    J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of quipazine on 5-HT metabolism in the rat brain.
    Hamon M; Bourgoin S; Enjalbert A; Bockaert J; Hery F; Ternaux JP; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):99-108. PubMed ID: 1004632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of serotoninmimetics in the behavioral despair test in rats.
    Górka Z; Wojtasik E; Kwiatek H; Maj J
    Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.